Funded Tech Companies
Adrenergics
Researching who backed Adrenergics? Private investors and Avalon Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Adrenergics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Adrenergics, Inc. develops therapeutics to treat dilated cardiomyopathy (DCM) in patients that do not respond to existing therapies. The company was incorporated in 2014.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/30/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Munk
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs